Tag: Brentuximab vedotin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Brentuximab vedotin

Seagen Earnings: Strong Sales Growth and Pipeline Makes Progress; Acquisition by Pfizer on Track

Added to Collection on: 2023-11-09 19:42:59

Tags for this article:

Breakthrough therapy
Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Antibody-drug conjugates
Seagen
Antibody-drug conjugate
Pembrolizumab
Transitional cell carcinoma
Enfortumab vedotin
Brentuximab vedotin
Chemotherapy
Padcev

Click the tags to see associated articles and topics

View Article Details
Disitamab vedotin shows promise in HER2+ metastatic urothelial carcinoma - Urology Times

Added to Collection on: 2023-12-07 20:20:14

Tags for this article:

Breakthrough therapy
Orphan drugs
Seagen
Antineoplastic drugs
Transitional cell carcinoma
Antibody-drug conjugates
Brentuximab vedotin
Genelux Corporation
vedotin

Click the tags to see associated articles and topics

View Article Details
Pfizer Reports First-Quarter 2024 Results - BioSpace

Added to Collection on: 2024-05-01 23:19:49

Tags for this article:

Pfizer
Research and development in the United States
Virus research
Pneumococcal conjugate vaccine
Seagen
Deployment of COVID-19 vaccines
Pharmaceutical industry
Respiratory syncytial virus
Navistar
Pfizer Inc.
United States
Prevnar
Brentuximab vedotin

Click the tags to see associated articles and topics

View Article Details
A Diagnosis of Lymphoma Has Changed My Life - The ASCO Post

Added to Collection on: 2024-11-08 21:00:16

Tags for this article:

Lymphoma
Hematology
Oncology
Brentuximab vedotin
CD30
Hodgkin lymphoma
Chemotherapy
Monomethyl auristatin E
Hematopoietic stem cell transplantation
Cancer
Radiation therapy
Seagen
Ethan Zohn

Click the tags to see associated articles and topics

View Article Details
Antibody Drug Conjugates Market To Surpass US$ 34 Billion By 2032 - EIN News

Added to Collection on: 2025-01-27 12:13:16

Tags for this article:

Antineoplastic drugs
Biotechnology
Immunology
Antibody-drug conjugates
Cancer treatments
Antibody-drug conjugate
Seagen
Targeted therapy
ImmunoGen
Chemotherapy
Breast cancer
Brentuximab vedotin
United States

Click the tags to see associated articles and topics

View Article Details
FDA Approves Pfizer Combination Regimen for Treating R/R Diffuse Large B-Cell Lymphoma

Added to Collection on: 2025-02-14 16:17:18

Tags for this article:

Lymphoma
Non-Hodgkin lymphoma
Antibody-drug conjugates
Brentuximab vedotin
Antibody-drug conjugate
Seagen
Monomethyl auristatin E
Diffuse large B-cell lymphoma
CD30
Indolent lymphoma
Pfizer
Lenalidomide
Rituximab

Click the tags to see associated articles and topics

View Article Details
EC approves Takeda's ADC for stage IIb Hodgkin lymphoma - Pharmaceutical Technology

Added to Collection on: 2025-06-04 13:51:37

Tags for this article:

Orphan drugs
Antibody-drug conjugates
IARC Group 2A carcinogens
Hodgkin lymphoma
Brentuximab vedotin
Chemotherapy regimen
Antibody-drug conjugate
CHOP
Doxorubicin
BEACOPP
Camidanlumab tesirine
Copp
Adcetris

Click the tags to see associated articles and topics

View Article Details
Antibody Drug Conjugates Market Hit USD 34.7 Billion by 2034 - London Daily News

Added to Collection on: 2025-06-30 16:06:11

Tags for this article:

Antineoplastic drugs
Biotechnology
Immunology
Antibody-drug conjugate
Genetic engineering
Pharmaceutical companies
Seagen
Targeted therapy
ImmunoGen
Brentuximab vedotin
Breast cancer
Chemotherapy

Click the tags to see associated articles and topics

View Article Details
B-Cell Lymphoma Market Expands with Therapy Innovations - Precedence Research

Added to Collection on: 2025-07-29 13:45:46

Tags for this article:

Lymphoma
Seagen
Diffuse large B-cell lymphoma
Targeted therapy
Non-Hodgkin lymphoma
B-cell lymphoma
Brentuximab vedotin
Antibody-drug conjugate
Cancer immunotherapy

Click the tags to see associated articles and topics

View Article Details
Immunotherapy for Hodgkin's lymphoma - MedicalNewsToday

Added to Collection on: 2025-09-01 16:57:32

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Nivolumab
Checkpoint inhibitor
Brentuximab vedotin
Hodgkin lymphoma
Pembrolizumab
Immunotherapy
Cancer treatment
Lymphoma
Passive antibody therapy
Hodgkin

Click the tags to see associated articles and topics

View Article Details
Book a Demo